What is a notable side effect of Mefloquine?

Mefloquine is primarily used as an antimalarial agent, and while it does have a range of potential side effects, teratogenicity is particularly notable. Teratogenic effects refer to the potential of a drug to cause developmental malformations in a fetus if taken during pregnancy.

Mefloquine has been associated with potential risks during pregnancy, and as such, it is generally recommended that its use be avoided in pregnant women unless absolutely necessary. Its safety profile is under scrutiny due to concerns regarding its impact on fetal development.

The other side effects associated with medications like Mefloquine, such as nephrotoxicity, cardiotoxicity, and hepatotoxicity, are less prominent in the context of Mefloquine specifically, making teratogenicity a key concern for healthcare professionals when considering its use in populations that include women of childbearing age or during pregnancy.